Literature DB >> 6533499

Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findings.

M Granowska, J Shepherd, K E Britton, B Ward, S Mather, J Taylor-Papadimitriou, A A Epenetos, M J Carroll, C C Nimmon, L A Hawkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6533499

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN： 0143-3636            Impact factor:   1.690


× No keyword cloud information.
  10 in total

1.  Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma.

Authors:  L Camera; S Del Vecchio; A Petrillo; G Esposito; G Frasci; R V Iaffaioli; A R Bianco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1991

Review 2.  Monoclonal antibody targeting of anti-cancer agents.

Authors:  R W Baldwin; V S Byers
Journal:  Springer Semin Immunopathol       Date:  1986

Review 3.  The development of new radiopharmaceuticals.

Authors:  K E Britton
Journal:  Eur J Nucl Med       Date:  1990

4.  Imaging of ovarian cancer with radiolabelled monoclonal antibodies.

Authors:  D L van Kranenburg; M J van Kroonenburgh; J B Trimbos; G J Fleuren; E K Pauwels
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

5.  A new approach to image subtraction in immunoscintigraphy: preliminary results.

Authors:  J C Liehn; P Hannequin; S Nasca; D Lebrun; A Cattan; J Valeyre
Journal:  Eur J Nucl Med       Date:  1987

Review 6.  The present and future of radiolabelled antibodies in oncology.

Authors:  K E Britton; M Granowska
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

7.  Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer.

Authors:  M Granowska; K E Britton; S J Mather; D G Lowe; D Ellison; J Bomanji; J Burchell; J Taylor-Papadimitriou; C R Hudson; J H Shepherd
Journal:  Eur J Nucl Med       Date:  1993-06

8.  The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage.

Authors:  R L Wahl; J Barrett; O Geatti; M Liebert; B S Wilson; S Fisher; J G Wagner
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

9.  Immunoscintigraphy of human lung squamous cell carcinoma using an iodine-131 labelled monoclonal antibody (Po66).

Authors:  P Bourguet; L Dazord; B Desrues; B Collet; M P Ramee; P Delaval; A Martin; Y Logeais; A Pelletier; L Toujas
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

10.  Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe.

Authors:  T E Ind; M Granowska; K E Britton; G Morris; D G Lowe; C N Hudson; J H Shepherd
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.